Neuropathic pain



Neuropathic pain





Prevalence

Neuropathic pain is estimated to affect about 1.5-3% of people worldwide1,2. The incidence of neuropathic pain varies among different pain syndrome categories (6.1)3. Diabetes mellitus is the most common medical condition resulting in neuropathy. Polyneuropathy occurs in one of every 4-5 patients with diabetes4,5. Painful neuropathy more commonly occurs in diabetics with long-duration illness and older age.

Painful neuropathies constitute a diverse collection of individual disorders, including conditions associated with direct nerve compression or trauma, such as mononeuropathy, radiculopathy, deafferentation pain, and reflex sympathetic dystrophy, and neuropathies related to other medical illnesses, such as peripheral polyneuropathy (Table 6.1). Several common unique neuropathic pain conditions are postherpetic neuralgia (PHN), trigeminal neuralgia, and complex regional pain syndrome (CRPS).






6.1 Incidence of painful neuropathies. A survey of 686 primary care practices in the United Kingdom identified the incidence of common painful neuropathies. (Based on Hall GC, et al., 20063.)








Table 6.1 Diverse neuropathic pain syndromes





























































Mononeuropathy



Carpal tunnel syndrome



Postmastectomy syndrome



Radiculopathy



Herniated nucleus pulposus



Polyneuropathy



Diabetes



Thyroid disease



Paraneoplastic syndrome



Alcoholism



Chemotherapy



HIV infection



Deafferentation syndrome



Phantom pain



Spinal cord injury



Poststroke pain



Complex regional pain syndrome (CRPS)



Reflex sympathic dystrophy (CRPS Type I)



Causalgia (CRPS Type II)




Postherpetic neuralgia

Herpes zoster characteristically begins with dermatomal pain or sensory disturbance, followed within hours to days by a painful papular rash in a dermatomal distribution (6.2). Papules change to vesicles and then become crusted. The acute zoster rash typically heals within 3-4 weeks. PHN is defined as pain that persists for >1 month after the onset of herpes zoster.

PHN occurs in about 30% of patients following acute zoster, and lasts 1 year in about 10% (6.3)6. The prevalence of PHN by dermatomal region and likelihood of improvement by region are shown in 6.47. PHN most commonly affects the trunk or face. Among patients with trigeminal distribution PHN, the ophthalmic division is usually affected. Risk factors for the development of PHN include female gender, older age, experiencing pain or sensory disturbance before the development of the rash, greater pain severity during acute herpes zoster, and larger distribution for zoster rash8. Persistent PHN increases in patients with older age and greater pain severity.







6.2 Typical thoracic herpes zoster. Acute lesions are shown in A. In patients developing postherpetic neuralgia (B), areas of allodynia (1), residual scarring (2), and sensory loss (3) may be identified.







6.3 Prevalence of PHN in patients with herpes zoster. A total of 204 primary care patients with acute shingles of ≤7 days with the diagnosis confirmed by laboratory testing were followed for up to 1 year in a prospective, observational study. Optimal antiviral therapy was started within 72 hours of symptom onset in 54% of patients, and delayed until after 72 hours in 25% of patients, usually due to delayed presentation to the family doctor. Antiviral therapy was predominantly with acyclovir (91% of treated patients). Patients >50 years old and those with moderate-severe pain at presentation were significantly more likely to develop PHN. (Based on Scott FT, et al., 20036.)






6.4 Epidemiology of PHN after herpes zoster. Pain features were retrospectively reviewed in 191 consecutive PHN patients, with a mean age of 68 ± 11 years. PHN most typically affected trigeminal and thoracic dermatomes (A), with pain right-sided in 52% of patients. Improvement by 75% or better (B) depended on pain location, with the best outcome for patients with pain in the face (especially the jaw), neck, and trunk. (Based on Bowsher D, 19967.)




Trigeminal neuralgia

Trigeminal neuralgia is experienced as a unilateral, intermittent, electric-shock-like jolt of pain into one or more of the divisions of the trigeminal nerve, usually over the cheek or jaw (6.5). Interestingly, pain more commonly affects the right side of the face9,10. Pain is typically triggered by activating a discrete trigger point on the face, such as with touching, shaving, talking, or chewing, often limiting the patient’s cooperation with a careful examination of the face and mouth. Curiously, patients with trigeminal neuralgia, as in the case presentation, will often sit holding the painful side of the face, possibly to prevent stimuli from activating their trigger point. In between pain episodes, some people experience a residual low level of pain over the face or jaw. Trigeminal neuralgia generally affects adults after age 40. Younger patients and patients with bilateral symptoms should be evaluated for multiple sclerosis. Although sensory loss occurs in a minority of patients with idiopathic trigeminal neuralgia, identifying sensory loss warrants evaluation with neuroimaging studies.






6.5 Location of trigeminal neuralgia pain. A: Nerve division affected; B: side of face affected. Pain distribution was evaluated in 44 patients treated at university settings in Singapore and Malaysia. There were no cases of trigeminal neuralgia pain affecting the ophthalmic division alone (A). Ophthamic plus maxillary pain occurred in one patient (2.3%). Most patients had mandibular pain (68.2%), with pain limited to the mandibular distribution for 50% of trigeminal neuralgia patients. Pain affected the maxillary division alone for 29.5% of patients and maxillary plus mandibular regions for 18.2%. Most patients had unilateral pain, more often affecting the right side of the face (B). (Based on Loh HS, et al., 19989.)








Table 6.2 Epidemiology of CRPS

























































United States


Netherlands


Incidence per 100,000





CRPS I


5.46


25.4



CRPS II


0.82


0.77


Mean age at diagnosis, years


46.9


52.7


Female:male ratio


4:1


3.4:1


Extremity affected


Twice as often upper


59% upper


Precipitating event (%)





Fracture


46


44



Sprain


12


18



Other


42


38


(Based on Sandroni P, et al., 200311; de Mos M, et al., 200712)




Complex regional pain syndrome

CRPS is a neuropathic pain that develops following limb injury or a period of limb immobilization (e.g. casting). CRPS may be divided into Type I (occurring in the absence of a nerve injury; formerly called reflex sympathetic dystrophy) and Type II (occurring after injury to a specific large nerve; formerly called causalgia). CRPS is characterized by excessive splinting and guarding of the painful extremity. Sympathetically-maintained pain and sympathetically-mediated pain are also terms formerly used to describe this syndrome. Failure of relief from sympathetic blocks, particularly in patients with long-standing complaints, led to the discontinuation of these terms.

The incidence of CRPS differs between the United States and Europe, although other epidemiological features are similar (Table 6.2)11,12. In the United States sample, symptoms resolved in 74% of cases, with a mean symptom duration of 1 year and a range of 1-60 months. Most patients rated treatment effectiveness good for physical therapy (87%), sympathetic blocks (79%), and prescription medication (80%).

Jul 5, 2016 | Posted by in PAIN MEDICINE | Comments Off on Neuropathic pain

Full access? Get Clinical Tree

Get Clinical Tree app for offline access